Providing upside to drugmakers, pharmaceutical spending continues to grow across emerging markets as a result of rising incomes and greater access to healthcare. However, protectionist policies and stringent price negotiations could dampen the promise of these new opportunities. Indeed, drugmakers will need to be aware of nuanced regional variations in order to tailor geographical strategy.
In this webinar, we provide critical analysis of the major trends and themes that we expect will impact pharmaceutical firms in 2020:
This commentary is produced by Fitch Solutions Macro Research and is NOT a comment about Fitch Ratings’ Credit Opinions or Credit Ratings. Nor is any of the background obtained from, or in conjunction with, Fitch Ratings credit analysts.